{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:50:51Z","timestamp":1762926651415,"version":"3.45.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,11]]},"DOI":"10.7759\/cureus.96628","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:45:12Z","timestamp":1762926312000},"source":"Crossref","is-referenced-by-count":0,"title":["A Double Threat in an Immunocompromised Patient: Coinfection With Pneumocystis jirovecii Pneumonia and Cytomegalovirus in Stomach Cancer"],"prefix":"10.7759","author":[{"given":"Rashmi  R","family":"Pattanayak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K Smita","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biswabikash","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1786561","article-title":"Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing polymerase chain reaction-based diagnosis in patients with Hodgkin lymphoma","volume":"61","author":"Barreto JN","year":"2020","unstructured":"Barreto JN, Thompson CA, Wieruszewski PM, et al.. Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing polymerase chain reaction-based diagnosis in patients with Hodgkin lymphoma. Leuk Lymphoma. 2020, 61:2622-9. 10.1080\/10428194.2020.1786561","journal-title":"Leuk Lymphoma"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.02106.x","article-title":"Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study","volume":"14","author":"Torres HA","year":"2008","unstructured":"Torres HA, Aguilera E, Safdar A, et al.. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect. 2008, 14:1160-6. 10.1111\/j.1469-0691.2008.02106.x","journal-title":"Clin Microbiol Infect"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3201\/eid1102.040487","article-title":"Pneumocystis jirovecii in general population","volume":"11","author":"Medrano FJ","year":"2005","unstructured":"Medrano FJ, Montes-Cano M, Conde M, et al.. Pneumocystis jirovecii in general population. Emerg Infect Dis. 2005, 11:245-50. 10.3201\/eid1102.040487","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.13105\/wjma.v11.i5.151","article-title":"Pulmonary cytomegalovirus infection: a case report and systematic review","volume":"11","author":"Kanika A","year":"2023","unstructured":"Kanika A, Soldera J. Pulmonary cytomegalovirus infection: a case report and systematic review. World J Metaanal. 2023, 11:151-66. 10.13105\/wjma.v11.i5.151","journal-title":"World J Metaanal"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3573-2","article-title":"Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors","volume":"154","author":"Waks AG","year":"2015","unstructured":"Waks AG, Tolaney SM, Galar A, et al.. Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors. Breast Cancer Res Treat. 2015, 154:359-67. 10.1007\/s10549-015-3573-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1467","article-title":"Serum indicators for the diagnosis of pneumocystis pneumonia","volume":"131","author":"Tasaka S","year":"2007","unstructured":"Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, Ishizaka A. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest. 2007, 131:1173-80. 10.1378\/chest.06-1467","journal-title":"Chest"},{"key":"ref7","unstructured":"CDC. Laboratory testing for CMV and congenital CMV, cytomegalovirus (CMV) and congenital CMV infection. (2025). Accessed: July 12, 2025: https:\/\/www.cdc.gov\/cytomegalovirus\/php\/laboratories\/index.html."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.37201\/req\/s03.16.2022","article-title":"Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies","volume":"35","author":"Garc\u00eda-Bustos V","year":"2022","unstructured":"Garc\u00eda-Bustos V, Salavert M, Blanes R, Caba\u00f1ero D, Blanes M. Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies. Rev Esp Quimioter. 2022, 35:74-9. 10.37201\/req\/s03.16.2022","journal-title":"Rev Esp Quimioter"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3816\/CBC.2008.n.041","article-title":"Lymphopenia associated with adjuvant anthracycline\/taxane regimens","volume":"8","author":"Tolaney SM","year":"2008","unstructured":"Tolaney SM, Najita J, Winer EP, Burstein HJ. Lymphopenia associated with adjuvant anthracycline\/taxane regimens. Clin Breast Cancer. 2008, 8:352-6. 10.3816\/CBC.2008.n.041","journal-title":"Clin Breast Cancer"},{"key":"ref10","article-title":"Pneumocystis jirovecii pneumonia","author":"Truong J","year":"2025","unstructured":"Truong J, Ashurst JV. Pneumocystis jirovecii pneumonia. StatPearls (Internet). StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12961","article-title":"The association between Cytomegalovirus co\u2010infection with Pneumocystis pneumonia and mortality in immunocompromised non\u2010HIV patients","volume":"12","author":"Ekren PK","year":"2018","unstructured":"Ekren PK, T\u00f6reyin ZN, Nahid P, et al.. The association between Cytomegalovirus co\u2010infection with Pneumocystis pneumonia and mortality in immunocompromised non\u2010HIV patients. Clin Respir J. 2018, 12:2590-7. 10.1111\/crj.12961","journal-title":"Clin Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/09564624251314567","article-title":"Pneumocystis jirovecii pneumonia co-infection with cytomegalovirus pneumonia in a patient with acquired immunodeficiency syndrome: a case report and literature review","volume":"36","author":"Techasupaboon T","year":"2025","unstructured":"Techasupaboon T, Nasomsong W. Pneumocystis jirovecii pneumonia co-infection with cytomegalovirus pneumonia in a patient with acquired immunodeficiency syndrome: a case report and literature review. Int J STD AIDS. 2025, 36:416-22. 10.1177\/09564624251314567","journal-title":"Int J STD AIDS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405988-a-double-threat-in-an-immunocompromised-patient-coinfection-with-pneumocystis-jirovecii-pneumonia-and-cytomegalovirus-in-stomach-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:45:13Z","timestamp":1762926313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405988-a-double-threat-in-an-immunocompromised-patient-coinfection-with-pneumocystis-jirovecii-pneumonia-and-cytomegalovirus-in-stomach-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.96628","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,11]]}}}